GlassScriptPhysician profile
Abdul Hussein Ali
NPI 1417620303
$577.80
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $578.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $147.03 | 2022 | |
| Bausch Health US, LLC | $66.37 | 2022 | |
| Alkermes, INC. | $60.37 | 2022 | |
| Janssen Pharmaceuticals, INC | $58.29 | 2022 | |
| Almatica Pharma LLC | $50.97 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $43.62 | 2022 | |
| Neurocrine Biosciences, INC. | $38.37 | 2022 | |
| Lundbeck LLC | $32.92 | 2022 | |
| Sunovion Pharmaceuticals INC. | $24.31 | 2022 | |
| Biogen, INC. | $22.71 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $19.28 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.56 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdul Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.